Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-3137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Role of Tif1γ Expression and Circulating Tumor Cells in Patients With Breast Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

Cancers
Cancer ResearchOncology
2020English

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Circulating Tumor Cell Count Could Be Used to Determine Treatment of Metastatic Breast Cancer

Cancer
Cancer ResearchOncology
2019English

Development and Validation of Nomograms for Predicting Survival in Patients With Non-Metastatic Colorectal Cancer

Oncotarget
Oncology
2017English

Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2007English

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2019English

Kinetics, Prognostic and Predictive Values of ESR1 Circulating Mutations in Metastatic Breast Cancer Patients Progressing on Aromatase Inhibitor

Oncotarget
Oncology
2016English

Development and Validation of Nomograms Predicting Survival in Chinese Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy